Microfluidic Quantitative PCR Detection of 12 Transgenes from Horse Plasma for Gene Doping Control

Genes (Basel). 2020 Apr 23;11(4):457. doi: 10.3390/genes11040457.

Abstract

Gene doping, an activity which abuses and misuses gene therapy, is a major concern in sports and horseracing industries. Effective methods capable of detecting and monitoring gene doping are urgently needed. Although several PCR-based methods that detect transgenes have been developed, many of them focus only on a single transgene. However, numerous genes associated with athletic ability may be potential gene-doping material. Here, we developed a detection method that targets multiple transgenes. We targeted 12 genes that may be associated with athletic performance and designed two TaqMan probe/primer sets for each one. A panel of 24 assays was prepared and detected via a microfluidic quantitative PCR (MFQPCR) system using integrated fluidic circuits (IFCs). The limit of detection of the panel was 6.25 copy/μL. Amplification-specificity was validated using several concentrations of reference materials and animal genomic DNA, leading to specific detection. In addition, target-specific detection was successfully achieved in a horse administered 20 mg of the EPO transgene via MFQPCR. Therefore, MFQPCR may be considered a suitable method for multiple-target detection in gene-doping control. To our knowledge, this is the first application of microfluidic qPCR (MFQPCR) for gene-doping control in horseracing.

Keywords: gene doping; horse; microfluidic qPCR; multiple-target detection; transgene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Athletic Performance
  • Doping in Sports / methods
  • Doping in Sports / prevention & control*
  • Erythropoietin / blood
  • Erythropoietin / genetics*
  • Horses
  • Male
  • Microfluidics / methods*
  • Real-Time Polymerase Chain Reaction / methods*
  • Transgenes*

Substances

  • Erythropoietin